mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.02 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.02 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
0.02 |